Evogene Ltd. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ALDX
Aldeyra Therapeutics, Inc. |
$4.95 | $229.34 M | -7.57 | 9 | $0 |
BDRX
Biodexa Pharmaceuticals Plc |
$4.29 | $222,107 | -0.09 | 21 | $381,000 |
CANF
Can-Fite BioPharma Ltd. |
$1.55 | $11.71 M | -0.82 | 8 | $743,000 |
CGEN
Compugen Ltd. |
$1.58 | $188.91 M | -11.72 | 68 | $33.46 M |
CKPT
Checkpoint Therapeutics, Inc. |
$3.50 | $68.32 M | -0.72 | 23 | $103,000 |
CLGN
CollPlant Biotechnologies Ltd. |
$3.57 | $58.76 M | -7.77 | 75 | $10.96 M |
CRVS
Corvus Pharmaceuticals, Inc. |
$5.21 | $126.98 M | -3.98 | 28 | $0 |
FATE
Fate Therapeutics, Inc. |
$1.61 | $418.90 M | -1.92 | 181 | $63.53 M |
GMDA
Gamida Cell Ltd. |
$0.03 | $4.34 M | -0.04 | 143 | $1.78 M |
ICCC
ImmuCell Corporation |
$4.98 | $35.08 M | -8.8 | 75 | $17.47 M |
LEXX
Lexaria Bioscience Corp. |
$2.25 | $46.84 M | -4.88 | 5 | $464,278 |
NAVB
Navidea Biopharmaceuticals, Inc. |
$0.00 | $10,008 | 0 | 11 | $65,652 |
ONCR
Oncorus, Inc. |
$0.13 | $3.29 M | -0.04 | 64 | $0 |
PLUR
Pluri Inc. |
$4.55 | $31.25 M | -1.41 | 106 | $326,000 |
PLX
Protalix BioTherapeutics, Inc. |
$1.82 | $82.11 M | 14 | 208 | $65.49 M |
RCUS
Arcus Biosciences, Inc. |
$15.27 | $1.41 B | -4.98 | 577 | $117.00 M |
SURF
Surface Oncology, Inc. |
$1.07 | $65.08 M | -0.69 | 35 | $30.00 M |
ZVSA
ZyVersa Therapeutics, Inc. |
$1.15 | $3.68 M | 0 | 7 | $0 |